Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 57 citing articles:

Current therapy and drug resistance in metastatic castration-resistant prostate cancer
Maoping Cai, Xian‐Lu Song, Xinan Li, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100962-100962
Open Access | Times Cited: 116
Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 44
Circular RNAs: Emerging roles and new insights in human cancers
Zhilin He, Qubo Zhu
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115217-115217
Open Access | Times Cited: 30
HDAC2 as a target for developing anti-cancer drugs
Hyein Jo, Kyeonghee Shim, Hanul Kim, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 2048-2057
Open Access | Times Cited: 28
Regulation of the tumor immune microenvironment by cancer-derived circular RNAs
Liping Guan, Qian Hao, Fenfen Shi, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 22
Taurine Inhibits Ferroptosis Mediated by the Crosstalk between Tumor Cells and Tumor‐Associated Macrophages in Prostate Cancer
Huixiang Xiao, Xinxing Du, Zhenkeke Tao, et al.
Advanced Science (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 21
NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8
Kang‐Jing Li, Yaying Hong, Yu‐Zhong Yu, et al.
Advanced Science (2024) Vol. 11, Iss. 32
Open Access | Times Cited: 11
Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells
Yijia Tang, Guangzu Cui, Haicong Liu, et al.
Cancer Communications (2024) Vol. 44, Iss. 6, pp. 601-636
Open Access | Times Cited: 10
The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression
Fujiao Nie, Jie Zhang, Haoyang Tian, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 9
Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/STAT3 axis in a colorectal cancer model
Zhenqiang Sun, Yanxin Xu, Bo Shao, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 5, pp. e008491-e008491
Open Access | Times Cited: 8
Current advances of liquid biopsies in prostate cancer: Molecular biomarkers
Murad Alahdal, Roshane Perera, Márcio Covas Moschovas, et al.
Molecular Therapy — Oncolytics (2023) Vol. 30, pp. 27-38
Open Access | Times Cited: 18
Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway
Xujun You, Junfeng Qiu, Qixin Li, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Circular RNAs in tumor immunity and immunotherapy
Wenjie Zhang, Xu Chen, Zhipeng Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Circular RNAs as Key Regulators in Cancer Hallmarks: New Progress and Therapeutic Opportunities
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Rohana Jaafar, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104612-104612
Open Access
Global research landscape and emerging trends of non-coding RNAs in prostate cancer: a bibliometric analysis
Yuliang Zhou, Wenliang Yao, Shenghui Chen, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Identification of pyrimidine metabolism-based molecular subtypes and prognostic signature to predict immune landscape and guide clinical treatment in prostate cancer
Yu‐Zhong Yu, Xiao Xie, Maoping Cai, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
A novel peptide encoded by circSRCAP confers resistance to enzalutamide by inhibiting the ubiquitin-dependent degradation of AR-V7 in castration-resistant prostate cancer
Xiannan Meng, Qingxuan Wu, Chengsong Cao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Tegaserod maleate exerts anti-tumor effects on prostate cancer via repressing sonic hedgehog signaling pathway
Maoping Cai, Shengdong Ge, Yaying Hong, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
The Use of Biologics for Targeting GPCRs in Metastatic Cancers
Cian McBrien, David O’Connell
BioTech (2025) Vol. 14, Iss. 1, pp. 7-7
Open Access
CCL20 in the tumor microenvironment: implications for cancer progression and therapeutic approaches
Louis Boafo Kwantwi, James Danquah Boafo, Bevelyn Emefa Egleh, et al.
Clinical & Translational Oncology (2025)
Open Access
Multiple roles of circular RNAs in prostate cancer: from the biological basis to potential clinical applications
Xianping Zheng, Ling Song, Ce Cao, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
TGFβ-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt/β-catenin signaling pathway
Shengdong Ge, Jinpeng Cen, Liu Xiao-feng, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101227-101227
Closed Access
New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials
Peng He, Qiang Dai, Xiaojun Wu
Environmental Research (2023) Vol. 229, pp. 115672-115672
Closed Access | Times Cited: 12
Tumour-associated macrophages: versatile players in the tumour microenvironment
Zoey Zeyuan Ji, Max Kam‐Kwan Chan, Alex Siu Wing Chan, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 11
Identification of a basement membrane gene signature for predicting prognosis and estimating the tumor immune microenvironment in prostate cancer
Tao Xie, Du-Jiang Fu, Kang‐Jing Li, et al.
Aging (2024) Vol. 16, Iss. 2, pp. 1581-1604
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top